Patent · US Active

Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (RSV) infection

US9079893B2 · kind B2 · utility

21Cited by

6References

1Claims

0Family size

Assignee

RESPIVERT LTD. · GB

Inventors

Lindsey Cass · London, GB
Kazuhiro Ito · London, GB
William Garth Rapeport · London, GB
Peter Strong · London, GB

Key dates

Filing date	Jun 17, 2011
Grant date	Jul 14, 2015
Priority date	—
Expiry date	Jul 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Medicinal use The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of respiratory syncitial virus (RSV) infection in particular viral exacerbation of a respiratory disorder such as bronchitis, asthma, COPD and/or cystic fibrosis, methods of treating or preventing RSV infection employing said compounds or pharmaceutical composition comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.